The FDA Advisory Committee has endorsed booster shots for the Johnson & Johnson vaccine in addition to Pfizer and Moderna.

This endorsement comes just one day after Moderna received the green light for a booster dose for those aged 65 and over who are at high risk for contracting the virus.

The panel said a booster should be offered at least two months after immunization, but did not suggest a firm time.